330 related articles for article (PubMed ID: 9578182)
21. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.
Fitzsimmons ME; Collins JM
Drug Metab Dispos; 1997 Feb; 25(2):256-66. PubMed ID: 9029057
[TBL] [Abstract][Full Text] [Related]
22. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice.
Hukkinen SK; Varhe A; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1995 Aug; 58(2):127-31. PubMed ID: 7648762
[TBL] [Abstract][Full Text] [Related]
23. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.
Damkier P; Hansen LL; Brosen K
Br J Clin Pharmacol; 1999 Dec; 48(6):829-38. PubMed ID: 10594487
[TBL] [Abstract][Full Text] [Related]
24. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
Hukkanen J; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
[TBL] [Abstract][Full Text] [Related]
25. Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir.
Culm-Merdek KE; von Moltke LL; Gan L; Horan KA; Reynolds R; Harmatz JS; Court MH; Greenblatt DJ
Clin Pharmacol Ther; 2006 Mar; 79(3):243-54. PubMed ID: 16513448
[TBL] [Abstract][Full Text] [Related]
26. Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics.
Penzak SR; Acosta EP; Turner M; Edwards DJ; Hon YY; Desai HD; Jann MW
J Clin Pharmacol; 2002 Oct; 42(10):1165-70. PubMed ID: 12362932
[TBL] [Abstract][Full Text] [Related]
27. CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro.
Eagling VA; Wiltshire H; Whitcombe IW; Back DJ
Xenobiotica; 2002 Jan; 32(1):1-17. PubMed ID: 11824416
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine.
Charbit B; Becquemont L; Lepère B; Peytavin G; Funck-Brentano C
Clin Pharmacol Ther; 2002 Nov; 72(5):514-23. PubMed ID: 12426515
[TBL] [Abstract][Full Text] [Related]
29. Effects of food and grapefruit juice on single-dose pharmacokinetics of blonanserin in healthy Chinese subjects.
Shang DW; Wang ZZ; Hu HT; Zhang YF; Ni XJ; Lu HY; Zhang M; Hu JQ; Qiu C; Peng H; Shen LF; Wen YG
Eur J Clin Pharmacol; 2018 Jan; 74(1):61-67. PubMed ID: 28975417
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
31. Grapefruit juice enhances the exposure to oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):782-8. PubMed ID: 20406214
[TBL] [Abstract][Full Text] [Related]
32. Influence of grapefruit juice on cisapride pharmacokinetics.
Gross AS; Goh YD; Addison RS; Shenfield GM
Clin Pharmacol Ther; 1999 Apr; 65(4):395-401. PubMed ID: 10223776
[TBL] [Abstract][Full Text] [Related]
33. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine.
Chan WK; Nguyen LT; Miller VP; Harris RZ
Life Sci; 1998; 62(10):PL135-42. PubMed ID: 9496718
[TBL] [Abstract][Full Text] [Related]
34. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
Kakar SM; Paine MF; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
[TBL] [Abstract][Full Text] [Related]
35. Grapefruit juice and saquinavir.
James JS
AIDS Treat News; 1995 Nov; (no 235):5-6. PubMed ID: 11363047
[TBL] [Abstract][Full Text] [Related]
36. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice.
Libersa CC; Brique SA; Motte KB; Caron JF; Guédon-Moreau LM; Humbert L; Vincent A; Devos P; Lhermitte MA
Br J Clin Pharmacol; 2000 Apr; 49(4):373-8. PubMed ID: 10759694
[TBL] [Abstract][Full Text] [Related]
37. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
Banfield C; Gupta S; Marino M; Lim J; Affrime M
Clin Pharmacokinet; 2002; 41(4):311-8. PubMed ID: 11978146
[TBL] [Abstract][Full Text] [Related]
38. Grapefruit juice substantially increases plasma concentrations of buspirone.
Lilja JJ; Kivistö KT; Backman JT; Lamberg TS; Neuvonen PJ
Clin Pharmacol Ther; 1998 Dec; 64(6):655-60. PubMed ID: 9871430
[TBL] [Abstract][Full Text] [Related]
39. Drug interactions with grapefruit juice.
Ameer B; Weintraub RA
Clin Pharmacokinet; 1997 Aug; 33(2):103-21. PubMed ID: 9260034
[TBL] [Abstract][Full Text] [Related]
40. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.
Bailey DG; Dresser GK; Kreeft JH; Munoz C; Freeman DJ; Bend JR
Clin Pharmacol Ther; 2000 Nov; 68(5):468-77. PubMed ID: 11103749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
